News Articles 121 - 130 of 160

Dame Shelia Sherlock Research Prize 2019 - apply now - deadline 10th June
News Type: BASL News

Deadline: 09:00 Monday 3rd June 2019

Each year BASL presents the Dame Sheila Sherlock research prize, one of the highlights of the annual meeting. This prize is awarded annually to recognise the enormous contribution of Dame Sheila Sherlock to the development of Hepatology as a discipline in its own right.

When Dr Sherlock started her medical career, little was known about liver disease. Her work helped to establish hepatology as a medical specialty. She pioneered the use of needle liver biopsy, which had been used purely as a research tool, based on the technique of Sir John McMichael; this improved understanding of the pathology of liver disease and is used in the diagnosis of liver diseases today. The liver unit that she set up at the Royal Free Hospital became the centre for both research into liver disease and the education of trainees in the specialty.

Dame Sheila was involved in the foundation of the British Liver Club in 1961, which subsequently evolved into The British Association for the Study of the Liver (BASL). She was one of our past presidents and the first recipient of The BASL Distinguished Service Award.

The winner of the award will deliver a 30 minute lecture presenting their research during the BASL Annual Meeting, 18-20 September 2019 at the University of Strathclyde, Glasgow. The prize is free registration to the meeting, a place at the Annual Dinner and £1,000.

In keeping with Dame Sheila’s enthusiasm for fostering young researchers, this eponymous research prize is awarded to young investigators without substantive posts in either medicine or science for their contributions in the field of hepatology research.

How to apply
Please send one A4 sheet outlining your research and another A4 sheet listing up to 5 related publications.

Please send submissions to before the deadline of 09:00 on Monday 10th June 2019.

News Type: BASL News


Are you a researcher interested in:

  • Childhood/paediatric liver conditions
  • Care of children with a liver condition
  • Paediatric liver transplantation
  • Psychological and social impact on those affected by a paediatric liver condition

Please note: Where appropriate applications for other paediatric chronic/long term conditions will be considered if the experience of our members would benefit the study

CLDF have recently developed a research hub which aims to increase and support patient and public involvement through our network of research hub members. Members are parents, carers, family members and young people affected by childhood liver conditions who have an interest in research design and supporting promotion of findings.
During the research hub trial stage, we are offering to support 2 research projects in 2019 which would benefit from patient and public involvement. If you would like to take advantage of this opportunity visit  to download the short application form or call 0121 212 6029. Deadline for applications is 12th July 2019 at 5pm. 

Gilead Sciences Grant Programs Supporting Investigator-Sponsored Research in Liver Diseases
News Type: BASL News

Gilead Sciences are pleased to announce the launch of five new global grants programs to continue to support investigator-sponsored research in chronic hepatitis C virus (HCV) and hepatitis B virus (HBV), HCV and HIV co-infection, non-alcoholic steatohepatitis (NASH) and primary sclerosing cholangitis (PSC). The programs seek to address pressing unmet patient needs in liver diseases, including improving screening and linkage to care, simplifying HCV testing and treatment, developing innovative referral pathways to help patients with NASH, addressing gaps in HBV care for special populations and understanding PSC epidemiology.

For more information on Gilead’s 2019 liver diseases grants programs, please visit .

The 2019 grant programs are:

HCV STAT (Simplification and Test and Treat Strategies toward HCV Elimination)
This program is focused on simplifying HCV care delivery and implementing test and treat strategies to overcome barriers to patient care.
Applications will be accepted from April 11 to June 30, 2019.

HIV/HCV NoCo (No Co-Infection)
This program is focused on investigating strategies to link patients living with HCV and HIV co-infection to HCV treatment.
Applications will be accepted from May 1 to June 14, 2019.

NASH Models of Care
This program will be focused on investigating care pathways between multidisciplinary providers for screening, identifying, and helping to refer, high-risk patients living with NASH, to appropriate medical care.
Applications will be accepted from June 3 to July 15, 2019.

HBV CARE (Linkage to CARe & Epidemiology in Special Populations)
This program will be focused on improving linkage to care among underserved populations and analysing or identifying data gaps in HBV epidemiology in specific demographics or geographies.
Applications will be accepted from August 1 to September 15, 2019.

PSC PACE (PrimAry Sclerosing Cholangitis Epidemiology)
This program will be focused on identifying gaps in PSC epidemiology data and improving understanding of the cascade of care.
Applications will be accepted from September 16 to October 11, 2019.

Vacancy - Senior Lecturer in Hepatology and Consultant Hepatologist at St George's
News Type: BASL News

Vacancy for Senior Lecturer in Hepatology and Consultant Hepatologist at St George's

St George's University of London and the trust's Department of Gastroenterology and Hepatology are looking to appoint an exceptional individual to this exciting new post. The post has been created for a self-motivated clinical academic to establish an independent research program at St George’s University of London, with clinical duties in a supportive and friendly department.

Please click on the link below: 

Closing date: 12th June 2019
Interview date: 27th June 2019

Vacancies - The Royal College of Physicians London
News Type: BASL News

The Royal College of Physicians has 2 Vacancies that members might be interested in: 


1. Clinical Director, Digital Health in London - click here to view, or visit the RCP website job page here -  .

Closing date: 4.00pm on Friday 3 May 2019.


2. Research & Academic Medicine committees: Two senior research-active clinicians - click here to view the commitee roles on the RCP website.

Closing date: Friday 3 May 2019.

Vacancy - two Senior Clinical Fellow posts in Hepatology and Liver Transplantation - Cambridge - deadline end of April 2019
News Type: BASL News

Applications are invited for two Senior Clinical Fellow posts in Hepatology and Liver Transplantation for twelve months, from 02 September 2019 to 04 September 2020 at Addenbrooke’s Hospital, Cambridge University Hospitals NHS Foundation Trust.

These posts are geared towards furthering a career in Hepatology. It is available to applicants who are within Gastroenterology/Hepatology training and wishing to seek an out of programme training/research period or to those who are seeking additional experience in tertiary Hepatology and Liver Transplantation following completion of training. The post could be extended subject to satisfactory progress particularly if pursuing out of programme research.

A breadth of subspecialist learning opportunities are available, depending on the applicants preference, which include tertiary level Hepatology, Liver Transplantation, Research or Management. For example in NASH, alcoholic hepatitis, HCC and PBC, we can offer involvement in translational research projects, in collaboration with research partners on the Cambridge Biomedical Campus, as well as involvement in Clinical Trials.

The successful candidates would both contribute to the Hepatology on call rota (1 in 8) and one of the posts will contribute no more than 4 weeks per six months to the general medical take rota.

These posts are not accredited as part of a speciality training programme but could be used for purposes as stated above.

Applicants must have demonstrable skills in listening, reading, writing and speaking in English that enable effective communication about medical topics with patients and colleagues, as set out in the GMC’s Good Medical Practice (2013).

Informal enquiries about this post should be addressed to Bill Griffiths (Specialty lead for Hepatology) at or Dr Victoria Snowdon (Consultant Hepatologist) at .

Deadline - end of April 2019.

End of Life SIG Lead - Expressions of Interest
News Type: BASL News

BASL has set up a number of Special Interest Groups (SIGs), which are linked to the NIHR’s Clinical Research Network (CRN) topic areas.

The End of Life SIG has been active for one year, with an initial lead appointed by the BASL Committee. BASL is now seeking nominations for an elected Lead for this SIG.

Eligibility requirements:

• All nominees should be members of the End of Life SIG, as a BASL member or as an associate member of BASL through being a member of the SIG

• Each nominee should have a proposer and seconder, who should also be BASL members or associate members through the End of Life SIG

• The initial Lead can stand for election once

• Should a contested election be held, BASL / End of Life SIG members may vote in this

• The elected Lead will serve for two years, when there will be a further election.

Nomination process:

Please send nominations to the BASL Secretariat at by 17:00 on 22nd March 2019

If more than one candidate is nominated, the Secretariat will arrange for an election, in which all BASL / End of Life SIG members may vote

Should an election be required, candidates will need to submit a personal statement of up to 300 words

The successful candidate will be elected by a simple majority of those members voting

Any queries should be addressed to

The role of the SIG Lead
A SIG is expected to meet at least once a year. The BASL secretariat provides administrative support for SIGs, which includes creating and maintaining SIG member databases, arranging meetings and associated materials, and arranging publicity.

The role of the SIG Lead includes:

• Chairing SIG meetings and co-ordinating actions to be pursued

• Helping to co-ordinate bids for funding for trials and other research, and linking with the NIHR and other funders

• Ensuring the SIG is recognised and supported within the Metabolic CRN topic area

• Reporting on SIG activities to BASL, in particular via liaison with BASL’s Research Subcommittee.

UKOSS is collecting data during pregnancy for women with Cirrhosis who become pregnant
News Type: BASL News

The UK Obstetric Surveillance System (UKOSS) is collecting data during pregnancy for women with Cirrhosis who become pregnant. This is an attempt to gather data on both numbers and outcomes of women with Pregnancy and Chronic Liver Disease in the UK.

The data collected so far can be viewed on the map here >  Download UKOSS map.pdf

The lead investigators are Professor Cath Williamson and Professor Michael Heneghan.

The ask from Hepatologists & BASL Membership is to let patients know who are pregnant to ask their local Obstetric service to include them in the data collection for the UKOSS Study. They are keen for liver centres that have still not reported any cases to be involved. 

The Surveillance Period end on 31st May 2019.

Thank you for your help.

News Type: BASL News

The 2019 ACCEA (Advisory Committee on Clinical Excellence Awards) round opens on Thursday 7th February 2019 and closes at 17:00 on Thursday 4th April 2019.

DEADLINE for applying for BASL support is 09:00 THURSDAY 7th MARCH 2019.

BASL will need to have completed the process of selecting those applicants who will receive our support well before the ACCEA deadline date.

If you wish to be considered for a national award in the 2019 round and you would like to seek BASL support, please complete and submit a copy of your ACCEA Application Form to BASL, along with any other supplementary CVQs; e.g. Research & Innovation (Form D), Teaching & Training (Form E), Medical Leadership & Managing a High Quality Service (Form F)

Applications should be sent to the BASL Secretariat to Judy Hawksworth at .

When submitting your application to BASL, please provide the name of an individual who has agreed to write your supporting citation. Please note: we will need to request a citation for every applicant even if the member is not successful in gaining BASL support, in order to meet the tight deadlines imposed by the ACCEA.

ACCEA regard the citations provided by BASL as important: they give added value to the process. The citation helps clarify information in the application and can put an individual's contribution into the wider context."

As in previous years BASL are able to support colleagues directly by nomination for national Gold, Silver and Bronze awards. As a specialist society, BASL cannot make nominations for Platinum awards; this must be done through the applicant’s University/Research Body and Universities UK. BASL can however provide a citation to support an application for a Platinum award.

How to apply for BASL support:

1. Send a copy of your completed ACCEA Application Form and other supplementary CVQs to the BASL Secretariat to by 09:00 on THURSDAY 7th March 2019. You must be a BASL member to request their support.

BASL also requires a short piece on your work with BASL and why you feel you should be supported by them. 

Please understand that in fairness to all applicants, late submissions will not be considered.

All applications are completed through the ACCEA on line system. The link to apply and downloadable copies of the application form and CVQ’s can be found on the ACCEA website and are intended to help those who wish to work on their application offline before completing them on the online system.  

Full application guidance can be found on the ACCEA website, including the use of the Supplementary Forms; 

2. When submitting your application to BASL, we ask that you provide the name and email address of an individual who has agreed to write your supporting citation upon sending your application. Please note: we will need to request a citation for every applicant even if the member is not successful in gaining BASL support, in order to meet the tight deadlines imposed by the ACCEA. 

3. Applications are scored independently by members of the BASL Committee.

4. If you are successful of BASL support then BASL will upload your citation to your application on the ACCEA website. It is your responsibility to ensure that you have completed your on line application to the ACCEA as per their instructions and regulations.

5. BASL will upload their supporting citations separately to their ranked lists. Individual scores are not submitted to the national panel but a ranked order for each award category is stated.

Should you have any questions, please do not hesitate to contact 

Clinics and Science in Hepatology - eLearning courses
News Type: BASL News

A series of free eLearning courses is now available online, based on the EACCME-accredited meeting ‘Clinics and Science in Hepatology’*, led by Course Directors Geoffrey Dusheiko and Maria Buti.

The courses are aimed at practising hepatologists, gastroenterologists and infectious disease specialists. Topics include:

  • Combating hepatitis C to reach elimination by 2030
  • Current management of HBV – focus on practical patient care
  • Current optimal management strategies for HBV
  • Management of HCV – current considerations

Visit to start a course and get your certificate.

Look out for more courses available online soon!

*EACCME accreditation for eLearning courses has been applied for. Decision pending.


NB: BASL have had no input into the eLearning course modules.